Glaxosmithkline reported $16.37B in Equity Capital and Reserves for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Amgen AMGN:US $ 2419M 1503M
AstraZeneca AZN:LN 35932M 408M
Aurora Cannabis Inc ACB:CN C$ 1.09B 864.57M
Bristol Myers Squibb BMY:US $ 32600M 1020M
Canopy Growth Corp WEED:CN C$ 1.64B 1.99B
Catalent CTLT:US $ 4632M 151M
Corcept Therapeutics CORT:US $ 442.33M 34.52M
Eli Lilly And LLY:US $ 8544.7M 786.1M
Endo International Ordinary Shares ENDP:US $ -1311M 67.01M
GlaxoSmithKline GSK:LN 16374M 193M
Glaxosmithkline GSK:US $ 16374M 193M
Horizon Pharma HZNP:US $ 4945.53M 127.7M
JAZZ PHA JAZZ:US $ 3200.78M 407.71M
Lannett LCI:US $ -159.31M 33.15M
Novartis NOVN:VX SF 62925M 1385M
Pacira Pharmaceuticals PCRX:US $ 756.64M 47.06M
Perrigo Ordinary Shares PRGO:US $ 5104.5M 47.2M
Phibro Animal Health PAHC:US $ 266.94M 27.65M
Prestige Brands PBH:US $ 1584.74M 7.13M
Supernus Pharmaceuticals SUPN:US $ 841.43M 12.99M
Takeda 4502:JP Y 6316832M 633813M
Teva Pharmaceutical TEVA:IT 9.04B 307M
Valeant Pharmaceuticals VRX:CN $ -216M 110M
Zoetis ZTS:US $ 4580M 78M